ArticleJournal of global health2022

Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?

Lorenzo Lo Muzio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.